You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
中國中藥(00570.HK)可能被控股股東國藥香港私有化 2月1日復牌
格隆匯 01-29 20:42

格隆匯1月29日丨中國中藥(00570.HK)公佈,公司董事會注意到一則日期為2021年1月27日的有關其控股股東國藥香港擬將公司私有化的新聞報道,謹此澄清如下。

公司已詢問國藥香港(公司控股股東,於本公吿日期持有16.35億股股份,約佔公司已發行股份總數32.46%),並被國藥香港吿知,其目前正研究將公司私有化的方案,若可能私有化進行,則有可能導致公司從聯交所退市。截至本公吿之日期,國藥香港尚未向公司提交有關可能私有化的確實方案。

此外,公司股票將於2020年2月1日復牌。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account